tiprankstipranks

James C. Blair Insider Profile

4 Followers
James C. Blair, Director at Clovis Oncology, holds 63.54K shares in Clovis Oncology (Ticker: CLVSQ), holds ― shares in aTyr Pharma (Ticker: LIFE), holds 0.00 shares in Cadence Pharma (Ticker: CADX). Most recently, James C. Blair Bought ― shares of Clovis Oncology on Aug 20, 2019 for an estimated value of 233.40K.
tipranks
James C. Blair

James C. Blair
Clovis Oncology (CLVSQ)
Director

Ranked #10,597 out of 98,564 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+48.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$757K
58.00%
18.81%
12.86%
8.85%
1.47% Others
A breakdown of James C. Blair's holdings

Insider Roles

Veracyte
(VCYT)
Ten Percent Owner
Alimera
(ALIM)
Ten Percent Owner
Vanda
(VNDA)
Ten Percent Owner
Esperion
(ESPR)
Ten Percent Owner
+2 other positions
Roles that James C. Blair holds in companies

Most Profitable Insider Trade

Stock:
Clovis Oncology
(CLVSQ)
Rating:Informative Sell
Date:Mar 18, 2019 - Mar 18, 2020
Return:+78.00%
The most profitable trade made by James C. Blair

James C. Blair's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CLVSQ
Clovis Oncology
Aug 20, 2019
Informative Buy
233.40K
$953.16
aTyr Pharma
Director
OCRX
Ocera Therapeutics
Jul 15, 2013
Informative Buy
7.99M
$6.31M
CLPM
Celator Pharmaceuticals
Jan 14, 2013
Informative Buy
$67.88M
ZGNX
Zogenix
Sep 20, 2011
Informative Buy
7.00M
$4.52M
~ACHN
Achillion Pharmaceuticals
Jan 18, 2013
Uninformative Buy
$1.65M
Esperion
Jul 02, 2013
Ten Percent Owner
Uninformative Buy
$66.98K
TBRA
Tobira Therapeutics
Aug 28, 2013
Uninformative Buy
$1.35M
SNMX
Senomyx
$91.18K
Vanda
Ten Percent Owner
$97.33K
AKAOQ
Achaogen
Mar 17, 2014
Uninformative Buy
$847.25
NUVA
NuVasive
$137.42K
Veracyte
Nov 04, 2013
Ten Percent Owner
Uninformative Buy
$438.92K
DRNA
Dicerna Pharma
Feb 04, 2014
Uninformative Buy
296.76K
$497.01K
OREXQ
Orexigen
Dec 22, 2011
Informative Buy
680.26K
$253.22
Alimera
Jun 03, 2011
Ten Percent Owner
Uninformative Buy
$142.36K
Evoke Pharma
Sep 30, 2013
Ten Percent Owner
Uninformative Buy
$11.11K
CADX
Cadence Pharma
Mar 21, 2014
Uninformative Sell
146.20M
SNTS
Santarus
SOMX
Somaxon Pharmaceuticals
PRTK
Paratek Pharmaceuticals
Jan 30, 2009
Informative Sell
238.75K
$151.36K
VOLC
Volcano Corp
DRTX
Durata
Jul 24, 2012
Uninformative Buy
List of latest transactions for each holding click on a transaction to see James C. Blair's performance on stock

James C. Blair insider profile FAQ

What is the percentage of profitable transactions made by James C. Blair?
The percentage of profitable transactions made by James C. Blair is 75%.
    What is the average return per transaction made by James C. Blair?
    The average return per transaction made by James C. Blair is 48.90%.
      What stocks does James C. Blair hold?
      James C. Blair holds: CLVSQ, LIFE, OCRX, CLPM, ZGNX, ~ACHN, ESPR, TBRA, SNMX, VNDA, AKAOQ, NUVA, VCYT, DRNA, OREXQ, ALIM, EVOK, CADX, SNTS, SOMX, PRTK, VOLC, DRTX stocks.
        What was James C. Blair’s latest transaction?
        James C. Blair latest transaction was an Informative Buy of $233.40K.
          What was James C. Blair's most profitable transaction?
          James C. Blair’s most profitable transaction was an Informative Sell of CLVSQ stock on March 18, 2019. The return on the trade was 78.00%.
            What is James C. Blair's role in Clovis Oncology?
            James C. Blair's role in Clovis Oncology is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.